Minneapolis Clinical Trials
Vaccine Study
Participate in a clinical study of a potential vaccine for adults to treat of infections caused by streptococcus bacteria such as pneumonia, meningitis and sepsis.
0 nights
2 visits
Purpose: to evaluate the safety and tolerability of an investigational medication for the prevention of infections caused by streptococcus bacteria such as pneumonia, meningitis and sepsis. There is one screening appointment and 1 outpatient visits. Reimbursement for study participation time and travel of up to $500 This study has been reviewed and approved by an independent ethics committee. Call 612-315-6490 to discuss your eligibility today! |
Eligibility
Age: 18 to 49
BMI: 18 to 40 kg/m2
Medications: Approved case by case basis
Compensation: Up to $500
Outpatient Visits: 2 outpatient visits; Visit 1 and Visit 2 (about 28 to 42 Days after Study Intervention Administration)